We caught up with Dr. John Yu, CEO & Chairman of Kairos Pharma (NYSE AM: KAPA) to discuss their novel therapies to overcome resistance to cancer drugs.
Get CEO.CA Pro
Real-time Level 2 Market Depth
Click for live demo